Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK.

Axel Anders Stefan LaurellAshwin V VenkataramanTatjana SchmidtMarcella MontagneseChristopher Mueller Robert J StewartJonathan LewisClare MundellJeremy D IsaacsMani S KrishnanRobert BarberTimothy RittmanBenjamin R Underwood

Published in: The British journal of psychiatry : the journal of mental science (2024)

Monoclonal antibody treatments for Alzheimer's disease are likely to present a significant challenge for healthcare services to deliver in terms of the neuroimaging and treatment delivery. The data provided here allows health services to understand the potential demand and plan accordingly.

Keyphrases

healthcare
monoclonal antibody
cognitive decline
primary care
electronic health record
human health
big data
artificial intelligence
data analysis
replacement therapy